Article info

Download PDFPDF

Original article
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

Authors

  1. Correspondence to Professor Günter Breithardt, Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany; g.breithardt{at}uni-muenster.de
View Full Text

Citation

Breithardt G, Baumgartner H, Berkowitz SD for the ROCKET AF Steering Committee & Investigators, et al
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

Publication history

  • Received May 21, 2015
  • Revised January 20, 2016
  • Accepted January 26, 2016
  • First published February 17, 2016.
Online issue publication 
June 10, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.